Anavex Life Sciences is a biopharmaceutical company based in New York that develops drugs. According to filings, it spent about $240,000 across five lobbying reports and hired the firm Forbes-Tate to lobby on health issues, specifically matters related to biopharmaceutical innovation. The filings show it is focused on policies affecting drug research and innovation.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BARRETT THORNHILL
The latest disclosures for this client.
FORBES-TATE
1TYFORBES-TATE
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
FORBES-TATE
mr RICHARD FERNANDO LOPEZ
FORBES-TATE
mr ARTHUR DENNIS SIDNEY
FORBES-TATE
WESLEY RYAN WELCH
FORBES-TATE
CYNTHIA BROWN
FORBES-TATE
FORBES-TATE
Q4FORBES-TATE
Q3FORBES-TATE
Q2FORBES-TATE
Q1FORBES-TATE
RR